Grace Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Grace Therapeutics Inc.
- Former names
- Acasti Pharma Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Princeton
- Headquarters state / province
- New Jersey
- Headquarters country
- Canada
- Fiscal year end
- March
- Ticker symbol
- GRCE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001444192
Board of directors
-
A. Brian Davis · DirectorSince 2023
-
Donald Olds · DirectorSince 2023
-
Edward Neugeboren · DirectorSince 2023
-
George Kottayil · DirectorSince 2023
-
Michael Derby · DirectorSince 2023
-
Prashant Kohli · Director · Chief Executive OfficerSince 2023
-
Vimal Kavuru · DirectorSince 2023
Chief executives
Prashant Kohli
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of September 12, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.5%
-
99.5%
-
99.6%
-
99.6%
Board connections
1 of this board's directors also sit on 1 other board.
- via Edward Neugeboren
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $301,789
- 6 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 23, 2026 | Opaleye Management Inc. 10% owner | Open-market purchase | +5,318 | $2.10 | $11,168 |
| Sep 21, 2026 | Opaleye Management Inc. 10% owner | Open-market purchase | +9,771 | $2.10 | $20,519 |
| Sep 9, 2026 | Prashant Kohli Director, Officer (Chief Executive Officer) | Open-market purchase | +100,000 | $2.14 | $214,000 |
| Sep 9, 2026 | Opaleye Management Inc. 10% owner | Open-market purchase | +5,836 | $2.09 | $12,197 |
| Sep 8, 2026 | Opaleye Management Inc. 10% owner | Open-market purchase | +9,393 | $2.10 | $19,699 |
| Aug 14, 2026 | Opaleye Management Inc. 10% owner | Open-market purchase | +11,608 | $2.09 | $24,206 |
| Sep 25, 2023 | Vimal Kavuru Director, 10% owner | Open-market purchase | +676,371 | $1.85 | $1,251,286 |
| Aug 31, 2023 | Donald Olds Director | Open-market purchase | +381 | $2.05 | $781 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.